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OBJECTIVE — Obesity and increases in body weight in adults are considered to be among
the most important risk factors for type 2 diabetes. Low birth weight is also associated with a
higher diabetes incidence. We aimed to examine to what extent the evolution of body shape,
from childhood to adulthood, is related to incident diabetes in late adulthood.
RESEARCH DESIGN AND METHODS — Etude Epidemiologique de Femmes de la
Mutuelle Ge ´ne ´rale de l’Education Nationale (E3N) is a cohort study of French women born in
1925–1950 and followed by questionnaire every 2 years. At baseline, in 1990, women were
askedtoreporttheircurrentweight,height,andbodysilhouetteatvariousages.Birthweightwas
recorded in 2002. Cases of diabetes were self-reported or obtained by drug reimbursement
record linkage and further validated.
RESULTS — Of the 91,453 women who were nondiabetic at baseline, 2,534 developed dia-
betes over the 15 years of follow-up. Birth weight and body silhouette at 8 years, at menarche,
and in young adulthood (20–25 years) were inversely associated with the risk of diabetes,
independently of adult BMI during follow-up (all Ptrend  0.001). In mid-adulthood (35–40
years), the association was reversed, with an increase in risk related to a larger body silhouette.
An increase in body silhouette from childhood to mid-adulthood ampliﬁed the risk of diabetes.
CONCLUSIONS — Low birth weight and thinness until young adulthood may increase the
risk of diabetes, independently of adult BMI during follow-up. Young women who were lean
children should be especially warned against weight gain.
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T
here are well-established associa-
tions between overweight or obesity
and type 2 diabetes (1,2). There is
also accumulating evidence indicating
that high weight in adolescence and early
adult life may affect later adult-onset dia-
betes (3,4). Conversely, many studies
have demonstrated associations between
lowbirthweight,aproxyforreducedfetal
growth, and diabetes or impaired glucose
toleranceinadultlife(5,6).Halesetal.(7)
suggested that diabetes was a conse-
quence of poor nutrition during critical
periods in fetal life and infancy with con-
sequent impaired development of -cell
function; a reduced ability to secrete in-
sulin would be a disadvantage if nutrition
became abundant. Eriksson et al. (8)
showed two different growth pathways
leading to type 2 diabetes: in babies with
below-average birth weight, although
there was an initial catch-up in growth
after birth, the BMI of those who later de-
veloptype2diabetesremainedbelowthat
of their peers until the age 7 years; and in
babies with above-average birth weight,
there was a higher risk for type 2 diabetes
if they had a more profound catch-down
growth after birth followed by a rapid in-
crease in weight and BMI after 2 years.
Moreover, an early adiposity rebound
seems to be associated with a higher risk
for later type 2 diabetes (9).
Despite this apparent paradox of an
association of type 2 diabetes with both
low birth weight and adult obesity, few
studies have investigated the impact of
body shape throughout life. In terms of
public health, it may be critical to deter-
mine at which period of life the associa-
tion between body shape and diabetes
risk reverses to tailor prevention recom-
mendations for diabetes to patients’ body
shape histories. In this study, we exam-
ined the inﬂuence of birth weight and
body silhouette, from childhood to mid-
dleage,onincidentdiabetesinacohortof
middle-aged French women born be-
tween 1925 and 1950.
RESEARCH DESIGN AND
METHODS— The Etude Epidemi-
ologique de Femmes de la Mutuelle Ge ´-
ne ´rale de l’Education Nationale (E3N)
prospectivecohortwasinitiatedinFrance
in 1990 to investigate risk factors for can-
cer in women (10). The cohort included
98,995 women living in France, aged
40–65 years at baseline, who were cov-
ered by the Mutuelle Ge ´ne ´rale de
l’Education Nationale, a National Health
Insurance Plan for teachers and cowork-
ers. All women signed an informed con-
sent form, in compliance with the rules of
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Computed Data and Individual Freedom
(Commission National Informatique et
Liberte ´s) from which approval was ob-
tained. Women completed baseline and
biennial self-administered questionnaires
with demographic and anthropometric
characteristics, reproductive history,
health status, lifetime use of hormonal
treatment, parental diabetes, and smok-
ing status. Follow-up questionnaires up-
dated information, especially on
medication use and menopausal status,
and recorded occurrence of major health
events, among which was diabetes.
Identiﬁcation and validation of
diabetes cases
A ﬁrst set of potential cases of diabetes
included women who had self-reported
either diabetes, a diet to manage diabetes,
use of diabetes drugs, or a hospitalization
for diabetes in at least one of the eight
questionnaires up until July 2005. A total
of 4,289 self-reported potential cases
were thus identiﬁed. Among them, 2,315
cases were validated when women were
identiﬁed from a drug reimbursement ﬁle
provided by the health insurance plan as
having been reimbursed for a diabetes
drug between 1 January 2004 (date when
the ﬁle became available) and 30 June
2007 (end point in the present study).
Among the 1,974 women without diabe-
tes drug reimbursement, women alive
and with an accurate address (n  1,735)
were mailed a questionnaire speciﬁcally
designed to validate diabetes. It included
questionsonthecircumstancesofdiagno-
sis (date of diagnosis, symptoms, and bi-
ological data including fasting or random
glucose concentrations at diagnosis), the
current therapy (prescription of diet
and/or physical activity and list of diabe-
tesdrugs),andthemonitoringofdiabetes
(last values of fasting glucose and A1C
levels). Among the 1,480 women who
completed this questionnaire (84% re-
sponse rate), 342 potential cases were
conﬁrmed when glucose at diagnosis was
reported to comply with World Health
Organization recommendations (fasting
glucose 7.0 mmol/l or random glucose
11.1 mmol/l) and/or when women re-
portedtakingdiabetesdrugsand/orwhen
their last values of fasting glucose or A1C
levels were reported to be 7.0 mmol/l
and/or 7%, respectively. In this ﬁrst set
ofpotentialcases,atotalof2,657diabetes
cases were thus validated. Among the
1,632 nonvalidated cases, 1,144 women
reported diabetes only once during the
follow-up.
A second set of women with potential
cases of diabetes was identiﬁed exclu-
sively from the drug reimbursement ﬁle
(n  1,216) without a prior report of di-
abetes in any of the eight study question-
naires. We mailed the diabetes-speciﬁc
questionnaire detailed above to 1,139 of
them and 734 women completed it. We
considered as noncases women who re-
ported being nondiabetic and who had
been reimbursed for diabetes drugs only
once before 30 June 2007 (n  233); we
validated as diabetic cases women who
conﬁrmed diabetes in the diabetes-
speciﬁcquestionnaire(n458)aswellas
those who did not answer the diabetes-
speciﬁc questionnaire but who received
reimbursement for diabetes drugs at least
twice (n  381). Other potential cases
were considered as nonvalidated (n 
144). Altogether, 3,496 diabetes cases
were validated up until 30 June 2007.
Although this procedure did not sys-
tematically allow differentiation between
type 1 and type 2 diabetes, very few inci-
dent cases of type 1 diabetes were ex-
pectedconsideringtheagerange.Women
with prevalent diabetes were excluded
from analyses (see below).
Body shape history
Birth weight. Women were asked about
their birth weight in the 2002 question-
naire. They could report their exact birth
weight, and we subsequently categorized
it as low (2,500 g), medium (2,500–
4,000 g), or high (4,000 g). Women
were also asked whether they had been
told they had a low, medium, or high
birth weight as a newborn (we used this
information when birth weight was miss-
ing, n  40,817) and whether their birth
was premature.
Body silhouette. Body silhouettes used
in the baseline questionnaire are shown in
supplemental Fig. 1 (available in an online
appendix at http://care.diabetesjournals.
org/cgi/content/full/dc09-1304/DC1). At
baseline, women provided information
on their body silhouette (11) at different
ages (8 years, menarche, 20–25 years,
and35–40years).Afour-levelcategorical
variable was used with values from 1
(leanestsilhouette)to4(thefourlargest
silhouettes were grouped together be-
cause of small numbers), except at age
35–40 years, at which categories were
ranked from 2t o5. Silhouette 3
seemed to be the best choice for a com-
mon reference category at all ages, given
the corresponding number of subjects at
each age.
BMI. BMIwascomputedateachfollow-up
(eight biannual questionnaires) from self-
reported weight and height.
Population for analysis and
follow-up
Weexcludedwomenwhodeclaredthem-
selves diabetic on the ﬁrst questionnaire
(n  715) as well as those with nonvali-
dated incident diabetes or with an un-
known date of diagnosis (n  1,968),
those with no follow-up after baseline
(n2,714),andthosewithmissingbase-
line BMI (n  2,145), leaving 91,453
women for analysis. Follow-up started at
thedateofreturnofthebaselinequestion-
naire. Women contributed person-time
until the date of diagnosis of diabetes,
dateoflastcompletedquestionnaireifthe
2005 questionnaire was not completed,
or 30 June 2007, whichever occurred
ﬁrst.
Statistical analysis
We used Cox proportional hazards re-
gressionmodelswithageasthetimescale
to estimate the hazards ratios (HRs) for
diabetesand95%CIassociatedwithbirth
weight categories or silhouettes at differ-
ent ages in separate models. In a more
global analysis of weight history over the
life course, subjects were categorized ac-
cording to birth category (low, medium,
or high), silhouette at 8 years (1, 2, or
3), and baseline BMI (overweight or
not) in an 18-level class variable. The HR
for each category of this variable was esti-
mated in reference to women with birth
weight in the medium class, silhouette 2
at 8 years, and baseline BMI 25 kg/m
2.
This analysis was restricted to subjects
without missing values for any of the
three variables. To respect the propor-
tional hazards assumption, analyses were
performed according to 5-year interval
birth cohorts using the STRATA option of
SAS PHREG procedure (SAS 9.1.3; SAS
Institute, Cary, NC). We controlled for
potential confounders by adjusting mod-
els for education level, baseline physical
activity, prematurity, parental history of
diabetes, high cholesterol level, age at
menarche, parity, and ever use of oral
contraceptive pills. Data on smoking,
menopausal status, use of menopause
hormonal therapy, hypertension, and
BMI were also considered as potential
confounders and analyzed as time-
dependent variables. Cutoffs for these
de Lauzon-Guillain and Associates
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Tables 2 and 3.
We replaced missing values by the
modal value (all were categorical vari-
ables) when data were missing in fewer
than 5% of women or else by a “missing”
category. We performed sensitivity anal-
yses that also included all nonvalidated
incident diabetes as diabetes cases and all
prevalent cases of diabetes. All analyses
were performed with SAS statistical soft-
ware (version 9.1).
RESULTS— Among the 91,453 women
studied, 2,534 cases of incident diabetes
were ascertained during a median follow-
upof15.1years.Characteristicsofthestudy
population according to diabetes status at
the end of the follow-up, are presented in
Table 1. The relationship between body
weight or silhouette at different ages
and diabetes risk was investigated (Ta-
ble 2).
Afteradjustmentforconfounders,the
risk of diabetes decreased with increasing
birth weight (Ptrend  0.001). This result
remained statistically signiﬁcant after ad-
ditional adjustment for adult BMI during
follow-up.
At 8 years, both a lean and a large
silhouette were associated with an in-
creased risk of incident diabetes. After
controlling for potential confounders, we
found that only the association with the
leanest silhouette remained statistically
signiﬁcant. This association was en-
hanced after controlling for adult BMI
during follow-up. Body silhouette at
menarche was inversely associated with
the risk of incident diabetes (Ptrend 
0.001),andtheassociationwasenhanced
after full adjustment.
Body silhouette at age 20–25 years
was positively associated with the risk of
diabetes (Ptrend  0.001), even after ad-
justmentforpotentialconfounders.How-
ever, the association reversed after
additional adjustment for adult BMI dur-
ing follow-up, with a decrease in risk
amongwomenwithalargesilhouetteand
an increased risk in lean women (Ptrend 
0.001). A signiﬁcantly increased risk of
diabeteswasassociatedwiththelargersil-
houettes at age 35–40 years. After con-
trolling for potential confounders and
additionally for adult BMI during follow-
up, we found that HRs were of a lower
magnitude,buttherelationshipremained
statistically signiﬁcant.
Adjustment for birth weight did not
substantially modify the above ﬁndings
(datanottabulated).Interactionsbetween
birth weight and body silhouettes were
also tested in the model adjusted for con-
founders,butnonewasstatisticallysignif-
icant. Missing values on silhouettes were
associated with a signiﬁcantly increased
diabetes risk, and they were more fre-
quent both among overweight or obese
women (P  0.001 for birth weight and
eachbodysilhouette,exceptatage20–25
years, P  0.012) and among older
women (P  0.001 for birth weight and
each body silhouette) independently.
Because self-reported birth weight
andbodysilhouettemaybeinﬂuencedby
baseline body weight, we investigated a
potential interaction between these vari-
ables and baseline BMI. A statistically sig-
niﬁcant interaction was found for birth
weight or body silhouettes (all P 
0.001). However, analyses stratiﬁed on
baseline overweight status (supplemen-
taryTable1,availableinanonlineappen-
dix) displayed associations between
diabetes risk and birth weight or body sil-
houette until early adulthood similar to
those presented in Table 2. Only the pos-
itive association between body silhouette
at 35–40 years and new-onset diabetes in
each subgroup was no longer signiﬁcant
after adjustment for BMI during fol-
low-up (all P  0.2).
In a more global analysis of weight
history over the life course (Table 3), as
compared with nonoverweight women
with medium birth weight and silhouette
2 at 8 years, women who were lean in
childhood were at higher risk for new-
onset diabetes. The highest risk for new-
onset diabetes was found for overweight
women who had low birth weight and
were lean in childhood. Finally, normal-
weight women who reported a larger sil-
houette in childhood, tended to have a
lower risk of diabetes. The only situation
for which a large silhouette in childhood
was not associated with a lower risk for
diabetes compared with a thinner silhou-
ettewasinoverweightwomenwithahigh
birth weight.
When women with validated and
nonvalidated cases of incident diabetes
wereincludedintheanalysis(n3,867),
the results remained similar to those pre-
sented above (data not tabulated). In a
sensitivity analysis, we also included
women with prevalent diabetes, and esti-
mates were consistent with the main re-
sults presented (data not shown).
CONCLUSIONS — In this large co-
hort study of French women, we de-
scribed a complex relationship between
body shape throughout life and adult-
onset diabetes. Low birth weight and
thinness from childhood to early adult-
hood increased the risk of diabetes, inde-
pendently of adult BMI. The association
between body silhouette from childhood
to adulthood and diabetes risk was not
modiﬁedbybirthweight.Comparedwith
having a medium silhouette both as a
child and as a middle-aged adult, an evo-
lution from a lean to a large silhouette
conferredthehighestrisk,whereasevolu-
Table 1—Characteristics of the E3N study population, according to diabetes status at the end
of the 17-year follow-up
No diabetes New-onset diabetes
n 88,919 2,534
Age (years) 49.3  6.6 51.3  6.7
BMI (kg/m
2) 22.5  3.0 26.9  4.7
Physical activity (MET-h/week) 52.3  38.0 44.3  35.8
At least one parent with diabetes (%) 9.6 23.7
Current smoker (%) 13.3 13.2
University degree (%) 35.2 24.4
Hypercholesterolemia (%) 8.2 15.2
Hypertension (%) 8.6 25.4
Menopause (%) 40.5 53.7
Low birth weight (%) 7.2 9.6
Body silhouette (1–8 scale)
At 8 years 1.8  1.1 1.8  1.2
At menarche 2.5  1.2 2.4  1.2
At 20–25 years 2.5  0.9 2.7  1.1
At 35–40 years 3.0  1.0 3.7  1.2
Data are means  SD or %. *Birth weight in grams categorized as low (2,500 g) or women’s self-
classiﬁcation as newborn of low birth weight (when birth weight in grams was missing).
Body silhouette history and incident diabetes
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lowest risk. Early adulthood (20–25
years)seemedtobeacriticalperiodwhen
the relationship between body silhouette
and diabetes reversed.
Because there is no birth weight reg-
istry for the whole French population, we
used self-reported birth weight, as in
other large studies (12–14). Potential
nondifferential misclassiﬁcation may oc-
cur and reduce the association; thus, the
actual association between low birth
weight and diabetes might be even stron-
ger than that reported here. A recent
systematicreviewsuggestedthattheasso-
ciation between birth weight and type 2
diabetesdecreasedlinearly(15),exceptin
native North American populations, in
whichthereisahighprevalenceofmater-
naldiabetes.Lowbirthweightmaybedue
to the duration of gestation. Although we
lacked information on the duration of
their mothers’ gestation, adjustment for
having been a premature baby did not
modify our results. This ﬁnding is consis-
tent with previous studies that have
shown, using precise information on the
length of gestation, that the relationship
betweensmallbirthweightandincidence
of type 2 diabetes was not explained by
prematurity.Arecentstudyshowedthata
genetic locus previously identiﬁed as a
marker of type 2 diabetes could also in-
ﬂuence birth weight, suggesting that the
association between low birth weight and
type 2 diabetes could be genetically me-
diated (16).
In addition to low birth weight, thin-
ness in childhood and adolescence was
associated with later diabetes risk. This
association with thinness in childhood
was previously shown by Eriksson et al.
Table 2—HRs (95% CI) for incident diabetes in relation to body silhouette history in the E3N cohort (1990–2007)
Cases of diabetes/person-years
(2,534/1,381,311)
HR (95% CI)
Model 1: adjusted for
year of birth
Model 2: adjusted for
confounders*
Model 3: adjusted for
confounders* and BMI†
Birth weight
Low 242/106,584 1.47 (1.29–1.69) 1.31 (1.13–1.53) 1.40 (1.20–1.62)
Medium 1,469/945,893 1 1 1
High 160/118,033 0.87 (0.74–1.03) 0.82 (0.70–0.97) 0.72 (0.61–0.85)
Missing 663/210,802 2.27 (2.07–2.49) 1.21 (1.04–1.41) 1.19 (1.02–1.39)
Ptrend 0.001 0.0001 0.0001
Body silhouette
At 8 years
1 1,440/711,442 1.35 (1.18–1.54) 1.35 (1.18–1.54) 1.66 (1.45–1.9)
2 423/276,290 1.06 (0.91–1.24) 1.10 (0.95–1.29) 1.28 (1.10–1.5)
3 260/178,920 1 1 1
4 255/144,255 1.22 (1.03–1.45) 1.15 (0.96–1.36) 1.09 (0.92–1.30)
Missing 156/70,404 1.46 (1.20–1.78) 1.21 (0.99–1.48) 1.45 (1.19–1.77)
Ptrend 0.0001 0.0001 0.0001
At puberty
1 599/296,009 1.14 (1.02–1.28) 1.16 (1.03–1.31) 1.48 (1.32–1.67)
2 808/430,164 1.09 (0.98–1.22) 1.08 (0.97–1.20) 1.23 (1.10–1.37)
3 545/320,388 1 1 1
4 449/285,608 0.93 (0.82–1.06) 0.90 (0.79–1.02) 0.81 (0.71–0.92)
Missing 133/49,143 1.51 (1.25–1.82) 1.15 (0.95–1.39) 1.26 (1.04–1.53)
Ptrend 0.0001 0.0001 0.0001
At 20–25 years
1 250/139,062 0.94 (0.81–1.08) 0.99 (0.86–1.14) 1.43 (1.23–1.65)
2 894/564,902 0.85 (0.78–0.94) 0.90 (0.82–0.99) 1.13 (1.03–1.25)
3 840/454,936 1 1 1
4 454/188,665 1.29 (1.15–1.45) 1.15 (1.03–1.29) 0.84 (0.75–0.95)
Missing 96/33,746 1.48 (1.20–1.83) 1.10 (0.89–1.36) 1.22 (0.98–1.51)
Ptrend 0.0001 0.001 0.0001
At 35–40 years
2 352/439,332 0.52 (0.46–0.59) 0.59 (0.52–0.66) 0.78 (0.69–0.88)
3 861/572,537 1 1 1
4 706/251,002 1.87 (1.69–2.06) 1.55 (1.40–1.71) 1.17 (1.05–1.29)
5 516/82,573 4.22 (3.78–4.71) 2.72 (2.43–3.05) 1.17 (1.03–1.32)
Missing 99/35,868 1.76 (1.43–2.16) 1.32 (1.07–1.63) 1.15 (0.93–1.42)
Ptrend 0.0001 0.0001 0.0001
n  91,453. *Model 2: includes physical activity (34/34–47/47–62/ 62 MET-h/week), education (9/10–11/12–14/15–16/17 years), prematurity (no/yes),
family history of diabetes (none/only one parent/both parents), smoking (never/former/current smoker, time-dependent variable), high cholesterol level (no/yes),
hypertension (no/yes, time-dependent variable), menopausal status (no/yes, time-dependent variable), hormone replacement therapy (never/ever, time-dependent
variable),oralcontraceptivepills(never/ever),parityandageatﬁrstchild(nulliparous/ﬁrstchildat30years,1–2children/ﬁrstchildat30years,3children/ﬁrst
childat30years),andageatmenarche(12/13/14yearsold),accordingtobirthcohort(1,925–1,930/1,930–1,935/1,935–1,940/1,940–1,945/1,945–1,950).
†Model 3: confounders as above and further adjustment for adult BMI as a time-dependent variable.
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between low weight gain between 6
months and 1 year and the risk of later
type 2 diabetes may be due to impaired
development of the endocrine pancreas,
because islet development continues
from late gestation until adolescence
(17,18).However,highBMIinchildhood
or adolescence has also been associated
with impaired glucose tolerance (19) and
even type 2 diabetes (20) in early adult-
hood. A rapid increase in BMI during
childhood was also found to be related to
higher plasma insulin levels (21). In our
study, few women reported either of the
two largest silhouettes (silhouettes 7 or 8)
at 8 years or at menarche (n  94 and
177, respectively), and we may have
lacked the power to detect associations
with a larger silhouette in early life. How-
ever, a lean silhouette in childhood was
not associated with the risk of diabetes in
overweight adult women with large birth
weight. As pointed out by Eriksson et al.
(8), the pathway leading to diabetes
seems to be different in subjects with low
and high birth weight. It is also notewor-
thy that the adjustment for adult BMI, by
inclusion as a time-dependent variable,
reinforced the associations between thin-
ness in childhood and adolescence and
diabetes risk. In our study, after we con-
trolled for BMI in middle-age, the body
silhouette at age 20–25 years was in-
verselyassociatedwiththeriskofincident
diabetes in middle age. This is the ﬁrst
cohortindicatingthattherelationshipbe-
tween body silhouette and risk of later-
onsetdiabetescouldreversesolateinlife.
Our results are consistent with previ-
ous observations that increases in BMI
from childhood to adulthood are an im-
portant risk factor for adult-onset diabe-
tes (1). Although increased adiposity is
the strongest risk factor for type 2 diabe-
tes (8,14), our results add evidence that
increased adiposity is particularly detri-
mental for those who have experienced
slow growth in utero but also throughout
childhood. In our cohort, the adjustment
for BMI in middle age increases the risk
associated with body silhouette in child-
hood but not with birth weight. Differ-
ences between studies for the latter point
may be related to the period in life when
overweight developed. In our sample of
French women born between 1925 and
1950, it occurred more often in early
adulthood.
A strength of our study is the large
number of participants and the large
number of women with incident cases of
diabetes from whom we were able to ob-
tain data on body silhouette from child-
hood to middle age. The exclusion of
women with nonvalidated cases of diabe-
tes limited misclassiﬁcation errors,
whereassensitivityanalysessuggestedthe
absence of a major selection bias. Analy-
seswerereplicatedwithallpotentialcases
ofdiabetes,andtheresultsweresimilar.A
limitation is the use of recalled body sil-
houette to estimate corpulence over the
lifecourse.However,avalidationstudyto
determine the accuracy of reported an-
thropometric measurements and per-
ceived body silhouettes showed a
correlation of 0.78 between BMI mea-
sured by technicians and the current self-
reported silhouette, with no signiﬁcant
differences between self-reported and
technician-measured mean BMI (22).
Body shape has been evaluated by recall
in other studies and found to be reliable
(23,24), providing a good ranking of past
corpulence and changes in corpulence
over time. Must et al. (23) reported that
the BMI percentile at menarche was well
correlated with recalled body size at this
period, after a recall time ranging from 23
to 33 years. The ability to recall events
around menarche appeared to be good in
that study, probably because the occur-
rence of the ﬁrst menstrual period is usu-
ally a disrupting event. Must et al. (23)
also described systematic recall biases,
with the thinnest girls overestimating
their body size, whereas normal and
heavier girls underestimated it. Such a
pattern was also observed among adult
womeninthevalidationstudyconducted
in our population (22). However, this
type of bias would tend to underestimate
any association between body silhouette
andincidentdiabetes.Inaddition,ourre-
sults were robust when we stratiﬁed anal-
yses by overweight status at baseline
(supplemental Table 1). Finally, an in-
creased risk of incident diabetes was ob-
served in the missing value category for
women with all body silhouette measure-
ments, a result that could be partially ex-
plained by the lower response rate among
overweight or obese women and among
older women. The prevalence of diabetes
assessed in French women, aged 60–69
years, was 8% in 2005 (25). In our co-
hort the prevalence of diabetes in women
of similar age at the end of the follow-up
was lower (3%). This difference may be
explained in part by a low prevalence of
obesity in our cohort (3% at inclusion).
Ourresultscouldthusbeverydifferentin
ayoungercohort,bornfromanincreasing
number of overweight mothers with glu-
cose intolerance, and experiencing over-
weight throughout childhood.
In summary, among women born in
1925–1950, both low birth weight and
thinness in childhood and early adult-
Table 3—Fully adjusted HRs (95% CI) for incident diabetes in relation to body shape history
over the life course, from birth to middle age, in the E3N cohort (1990–2007)
BMI 25 kg/m
2 at baseline BMI 25 kg/m
2 at baseline
Cases/total
person-years HR (95% CI)*
Cases/total
person-years HR (95% CI)*
Low birth weight
Silhouette 1 at 8 years 71/63,063 1.78 (1.31–2.43) 22/9,232 4.83 (3.62–6.45)
Silhouette 2 at 8 years 426/13,127 1.35 (0.72–2.53) 174/1,968 3.12 (1.77–5.50)
Silhouette 3 at 8 years 29/11,005 1.48 (0.79–2.77) 22/3,368 3.11 (1.99–4.87)
Medium birth weight
Silhouette 1 at 8 years 71/428,348 1.64 (1.32–2.05) 25/60,075 3.45 (2.75–4.33)
Silhouette 2 at 8 years 297/169,633 1 208/29,037 2.80 (2.16–3.61)
Silhouette 3 at 8 years 13/171,261 0.72 (0.53–0.97) 42/43,203 2.05 (1.59–2.63)
Large birth weight
Silhouette 1 at 8 years 29/35,825 1.34 (0.88–2.03) 15/6,227 1.43 (0.89–2.30)
Silhouette 2 at 8 years 138/19,044 0.67 (0.33–1.38) 150/4,155 2.22 (1.41–3.52)
Silhouette 3 at 8 years 8/34,896 0.63 (0.36–1.10) 31/11,933 1.77 (1.25–2.50)
*Adjusted for physical activity (34/34–47/47–62/2 MET-h/week), education (9/10–11/12–14/15–
16/17 years), prematurity (no/yes), family history of diabetes (none/only one parent/both parents), smok-
ing (never/former/current smoker, time-dependent variable), high cholesterol level (no/yes), hypertension
(no/yes, time-dependent variable), menopausal status (no/yes, time-dependent variable), hormone replace-
ment therapy (never/ever, time-dependent variable), oral contraceptive pills (never/ever), parity and age at
ﬁrst child (nulliparous/ﬁrst child at 30 years, 1–2 children/ﬁrst child at 30 years, 3 children/ﬁrst child
at 30 years or more), age at menarche (12/13/14 years old), and adult BMI as a time-dependent
variable, according to birth cohort (1,925–1,930/1,930–1,935/1,935–1,940/1,940–1,945/1,945–1,950).
Body silhouette history and incident diabetes
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risk of diabetes in middle age, indepen-
dent of adult BMI. An increase in body
silhouette from childhood to mid-
adulthood increased diabetes risk.
Weightgainpreventionprogramsneedto
be implemented to prevent diabetes in
young adult women, especially among
those who were lean in childhood.
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